Turn Therapeutics Inc. (TTRX)
NASDAQ: TTRX · Real-Time Price · USD
3.360
+0.030 (0.90%)
At close: Apr 7, 2026, 4:00 PM EDT
3.380
+0.020 (0.60%)
After-hours: Apr 7, 2026, 7:12 PM EDT

Turn Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22
99116---
Enterprise Value
94113---
Last Close Price
3.333.94---
PB Ratio
20.9224.75---
P/TBV Ratio
26.1930.82---
Debt / Equity Ratio
0.020.02-0.680.290.07
Net Debt / Equity Ratio
-1.07-1.074.24-13.48-1.75
Net Debt / EBITDA Ratio
0.860.860.430.510.49
Quick Ratio
0.850.851.232.411.22
Current Ratio
0.870.871.552.451.23
Return on Equity (ROE)
-141.67%-141.67%--369.43%-
Return on Assets (ROA)
-51.53%-51.53%-55.30%-58.56%-
Return on Capital Employed (ROCE)
-95.10%-95.10%-134.00%-151.50%-353.90%
Earnings Yield
-3.24%-2.75%---
Buyback Yield / Dilution
-3.24%-3.24%-1.33%--
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q